Glenn J. Lesser, M.D.
Affiliations: | Neurosurgery | Wake Forest University School of Medicine, Winston-Salem, NC, United States |
Area:
GBM, cancer/oncogenesis, drugs/therapeutic agentsWebsite:
http://www.wakehealth.edu/faculty/lesser-glenn-j.htmGoogle:
"Glenn Lesser"Mean distance: 106866
Collaborators
Sign in to add collaborator| National Brain Tumor Society | collaborator | National Brain Tumor Society |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Renfrow JJ, Soike MH, West JL, et al. (2020) Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Scientific Reports. 10: 15195 |
| Bower A, Hsu FC, Weaver KE, et al. (2020) Community economic factors influence outcomes for patients with primary malignant glioma. Neuro-Oncology Practice. 7: 453-460 |
| Fisher BJ, Pugh SL, Macdonald DR, et al. (2020) Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424. International Journal of Radiation Oncology, Biology, Physics |
| Lycan TW, Hsu FC, Ahn CS, et al. (2020) Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer. Muscle & Nerve |
| Lee EQ, Weller M, Sul J, et al. (2020) Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients. Neuro-Oncology |
| Dent SF, Reding K, Lesser GJ, et al. (2020) Understanding and predicting fatigue, cardiovascular (CV) decline & events after breast cancer treatment (UPBEAT): A prospective multi-center wake forest NCORP research-base study. Journal of Clinical Oncology. 38: TPS602-TPS602 |
| Bell EH, Pugh SL, Fisher BJ, et al. (2020) Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424. Journal of Clinical Oncology. 38: 2518-2518 |
| Wen PY, Reardon DA, Armstrong TS, et al. (2019) A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Cramer CK, Cummings TL, Andrews RN, et al. (2019) Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients. Current Treatment Options in Oncology. 20: 42 |
| Reding K, D'Agostino R, Lesser GJ, et al. (2019) Understanding and predicting fatigue, cardiovascular (CV) decline, and events after breast cancer treatment (UPBEAT): A prospective cardio-oncology study. Journal of Clinical Oncology. 37: TPS11634-TPS11634 |